Interferon and the central nervous system

European Journal of Pharmacology

Volumn 523, Issue 1-3, 2005, Pages 1-15

  Dafny, Nachum ^a   Yang, Pamela B ^a  

^a NONE

Author keywords

Beta; Endocrine; Food; Gamma; Glucose sensitive; Immune; Interferon alpha; Naloxone; Opiate; Sleep; Temperature

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CORTICOTROPIN; GAMMA INTERFERON; GLUCOSE; INTERFERON; INTERFERON RECEPTOR; INTERMEDIN; MELATONIN; MORPHINE; NALOXONE; OPIATE; OREXIN; PER1 PROTEIN; PROTEIN BMAL1; STAT PROTEIN; TRANSCRIPTION FACTOR CLOCK;

ANOREXIA; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BODY TEMPERATURE; BONE MARROW TUMOR; BRAIN REGION; CATAPLEXY; CELL COMMUNICATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CHRONIC MYELOID LEUKEMIA; CIRCADIAN RHYTHM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DROWSINESS; DRUG RECEPTOR BINDING; E BOX ELEMENT; ENZYME ACTIVATION; FEVER; FOOD INTAKE; GLIA CELL; HAIRY CELL LEUKEMIA; HEPATITIS B; HEPATITIS C; HUMAN; HYPNAGOGIC HALLUCINATION; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHERMIA; IMMUNE SYSTEM; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INSOMNIA; KAPOSI SARCOMA; LYMPHOMA; MACROPHAGE; MONOCYTE; MULTIPLE SCLEROSIS; NARCOLEPSY; NERVE CELL; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; OPIATE ADDICTION; PAIN; PARASOMNIA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SLEEP; SLEEP WAKING CYCLE; SUPRACHIASMATIC NUCLEUS; T CELL LYMPHOMA; T LYMPHOCYTE; VIRUS INFECTION; VIRUS REPLICATION; WITHDRAWAL SYNDROME;

ANIMALS; ANOREXIA; BODY TEMPERATURE REGULATION; BRAIN; CENTRAL NERVOUS SYSTEM; EATING; ENDOCRINE SYSTEM; ENERGY METABOLISM; FEVER; GLUCOSE; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNOLOGIC FACTORS; INTERFERONS; NARCOTICS; NEURONS; RECEPTORS, INTERFERON; RECEPTORS, OPIOID; SLEEP STAGES;

EID: 27644574882     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.08.029     Document Type: Review

References (235)

1. S.K. Ackerman, H.D. Hochstein, K. Zoon, W. Browne, E. Rivera, and B. Elisberg Interferon fever: absence of human leukocytic pyrogen response to recombinant α-interferon J. Leukoc. Biol. 36 1994 17 25
2. F. Adams, F. Fernandez, and G. Mavligit Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities J. Neurooncol. 6 1988 355 359
3. G.R. Adolf Structure and effects of interferon-gamma Oncology 42 1985 33 40
4. 125I-labeled mouse interferon to specific cell surface receptors Nature 284 1980 459 461
5. M. Aguet, and K.E. Mogensen Interferon receptors I. Gresser Interferon 1983 Academic Press London 1 22
6. G. Barbieri, L. Velazquez, M. Scrobogna, M. Fellous, and S. Pellegrini Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta Eur. J. Biochem. 223 1994 427 435
7. S. Baron, S.K. Tyring, W.R. Fleischmann, D.H. Coppenhaver, D.W. Niesel, G.R. Klimpel, G.J. Stanton, and T.K. Hughes The interferons: mechanisms of action and clinical applications J. Am. Med. Assoc. 266 1991 1375 1383
8. 1-24 and with B-MSH Life Sci. 29 1981 249 252
9. H.O. Besedovsky, and A. Del Rey Introduction: immune-neuroendocrine network Front. Horm. Res. 29 2002 1 14
10. H.O. Besedovsky, E. Sorkin, M. Keller, and J. Muller Changes in blood hormone levels during immune-response Proc. Soc. Exp. Biol. Med. 150 1975 466 473
11. H.O. Besedovsky, E. Sorkin, D. Felix, and H. Haas Hypothalamic changes during the immune response Eur. J. Immunol. 7 1977 325 333
12. H. Besedovsky, A. Del Rey, E. Sorkin, and C.A. Dinarello Immuno-regulatory feedback between interleukin-1 and glucocorticoid hormones Science 233 1986 652 654
13. B. Birmanns, D. Saphier, and O. Abramsky α-Interferon modifies cortical EEG activity: dose-dependence and antagonism by naloxone J. Neurol. Sci. 100 1990 22 26
14. C.A. Biron Interferons α and β as immune regulators - a new look Immunity 14 2001 661 664
15. C.A. Biron, and G.C. Sen D. Knipe P. Howley D. Griffin R. Lamb M. Martin S. Straus Fields Virology 2001 Lippincott, Williams and Wilkins Philadelphia, PA 469 513
16. J.E. Blalock A molecular basis for bidirectional communication between the immune and neuroendocrine systems Physiol. Rev. 69 1989 1 32
17. J.E. Blalock, and E.M. Smith Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins Proc. Natl. Acad. Sci. U. S. A. 77 1980 5972 5974
18. J.E. Blalock, and E.M. Smith Human leukocyte interferon (HuIFN-α) potent endorphin-like opioid activity Biochem. Biophys. Res. Commun. 101 1981 472 478
19. J.E. Blalock, and E.M. Smith Structure and function of interferon (IFN) and neuroendocrine hormones E. De Maeyer G. Galasso H. Schellekens The Biology of the Interferon System 1981 Elsevier Amsterdam 93 99
20. J.E. Blalock, and J.D. Stanton Common pathways of interferon and hormonal action Nature 283 1980 406 408
21. C.M. Blatteis, L. Xin, and N. Quan Neuromodulation of fever: apparent involvement of opioids Brain Res. Bull. 26 1991 219 223
22. V. Bocci The physiological interferon response Immunol. Today 6 1985 7 9
23. V. Bocci Central nervous system toxicity of interferons and other cytokines J. Biol. Regul. Homeost. Agents 2 1988 107 121
24. V. Bocci What are the roles of interferons in physiological conditions? Nips 3 1988 201 203
25. V. Bocci Physicochemical and biologic properties of interferons and their potential uses in drug delivery systems Crit. Rev. Ther. Drug Carr. Syst. 9 1992 91 133
26. V. Bocci, L. Paulesu, M. Muscettola, and A. Viti The physiologic interferon response: VI. Interferon activity in human plasma after a meal and drinking Lymphokine Res. 4 1985 151 158
27. U. Boehim, T. Klamp, M. Groot, and J. Howard Cellular responses to interferon-gamma Ann. Rev. Immunol. 15 1997 740 795
28. S.L. Brown, and D.E. VanEpps Opioid peptides modulate production of interferon gamma by human mononuclear cells Cell. Immunol. 103 1986 19 26
29. K. Bullock Neuroanatomy of lymphoid tissue: a review R. Guillemin M. Cohn T. Melnechuk Neural Modulaction of Immunity 1985 Raven Press New York, NY 111 128
30. D.P. Cadinali, and A.I. Esquifino Circadian disorganization in experimental arthritis NeuroSignals 12 2003 267 282
31. M.C. Calvert, and I. Gresser Interferon enhances the excitability of cultured neurons Nature 278 1979 558 560
32. I.L. Campbell, T. Krucker, S. Steffenson, Y. Akwa, H.C. Powell, T. Lane, D.J. Carr, L.H. Gold, S.J. Henriksen, and G.R. Siggins Structural and functional neuropathology in transgenic mice with CNS expression of IFN-α Brain Res. 835 1999 46 61
33. K. Cantell, E. Pulkkinen, R. Eluoso, and J. Suominen Effect of interferon on severe psychiatric diseases Ann. Clin. Res. 12 1980 131 132
34. C. Carelli, F. Audibert, J. Gaillard, and L. Chedid Imunological castration of mail mice by totally synthetic vaccine administration in saline Proc. Natl. Acad. Sci. U. S. A. 79 1982 5392 5395
35. D.J.J. Carr, A. Al-khatib, C.M. James, and R. Silverman Interferon-β suppresses herpes simplex virus type I replication in trigeminal ganglion cells through an RNase L-dependent pathway J. Neuroimmunol. 141 2003 40 46
36. F. Cathala, and S. Baron Interferon in rabbit brain, cerebrospinal fluid and serum following administration of polyinosinic-polycytidylic acid J. Immunol. 104 1970 1355 1358
37. L. Chemello, L. Cavalletto, E. Bernardinello, S. Boccato, P. Casarin, F. Cavinato, F. Urban, P. Pontisso, A. Cecchetto, A. Gatta, and A. Alberti Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C TVVH Study Group J. Viral Hepatitis 6 1999 321
38. M.Y. Cheng, C.M. Bullock, C. Li, A.G. Lee, J.C. Bernak, J. Belluzzi, D.R. Weaver, F.M. Leslie, and Q.Y. Zhou Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus Nature 417 2002 405 410
39. M. Cohen, A.S. Keats, W. Krivoy, and G. Ungar Effect of actinomycin D on morphine tolerance Proc. Soc. Exp. Biol. Med. 119 1965 381 384
40. O.R. Colamonici, H. Yan, P. Domanski, R. Hands, D. Smalley, J. Mullersman, M. Witte, K. Krishnan, and J.J. Krolewski Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase Mol. Cell. Biol. 14 1984 8133 8142
41. O.R. Colamonici, H. Uyttendaele, P. Domanski, H. Yan, and J.J. Krolewski p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor J. Biol. Chem. 269 1994 3518 3522
42. J.R. Cooper, F.E. Bloom, and R.H. Roth The Biochemical Basis of Neuropharmacology seventh ed. 1986 Oxford University Press New York, NY 9 48
43. A. Creange, H. Lerat, C. Meyrignac, J.D. Degos, R.K. Gherardi, and P. Cesaro Treatment of Guillain-Barre syndrome with interferon-beta Lancet 352 1998 368 369
44. L.S. Crnic, and M. Segall Behavioral effects of mouse interferons-α and -γ and human interferon-α in mice Brain Res. 590 1992 277 284
45. R. D'Urso, P. Falaschi, G. Canfalone, E. Carusi, A. Proietti, V. Barnaba, and F. Balsano Neuroendocrine effects of recombinant α-interferon administration in humans Prog. Neuroendocrinol. Immunol. 4 1991 20 29
46. N. Dafny Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats Neurotoxicology 4 1983 235 240
47. N. Dafny Modification of morphine withdrawal by interferon Life Sci. 32 1983 3303 3305
48. N. Dafny Interferon modifies morphine withdrawal phenomena in rodents Neuropharmacology 22 1983 647 651
49. N. Dafny Interferon as a candidate endogenous substance preventing tolerance and dependence to brain opioids Prog. Neuro-Psychopharmacol. Biol. Psychiatry 8 1984 351 357
50. N. Dafny Interferon as an endocoid candidate preventing and attenuating opiate addiction H. Lal F. Labella J. Lane Endocoids 1985 Alan R. Liss Inc. New York, NY 269 276
51. N. Dafny Effects of interferon on the central nervous system A.T. Reder Interferon Therapy of Multiple Sclerosis 1997 Marcel Dekker Inc. New York, NY 115 137
52. N. Dafny Is interferon-α a neuromodulator? Brain Res. 26 1998 1 15
53. N. Dafny Interferon and the central nervous system N.P. Plotnikoff Cytokines: Stress and Immunity 1999 CRC Press Boca Raton, FL 221 232
54. N. Dafny, and E.D. Jacobson Gastrointestinal hormones and neural interaction with the central nervous system Experimentia 31 1975 658 659
55. N. Dafny, and C. Reyes-Vazquez Three different types of α-interferons alter naloxone-induced abstinence in morphine-addicted rats Immunopharmacology 9 1985 13 17
56. N. Dafny, and C. Reyes-Vazquez Single injection of three different preparations of α-interferon modifies morphine abstinence signs for a prolonged period Int. J. Neurosci. 32 1987 953 961
57. N. Dafny, M. Zielinski, and C. Reyes-Vazquez Alteration of morphine withdrawal to naloxone by interferon Neuropeptides 3 1983 453 463
58. N. Dafny, B. Prieto-Gomez, and C. Reyes-Vazquez Does the immune system communícate with the central nervous system? Interferon modifies central nervous system activity J. Neuroimmunol. 9 1985 1 12
59. N. Dafny, V.G. Wagle, and D.B. Drath Cyclosporine A alters opiate withdrawal in rodents Life Sci. 36 1985 1721 1726
60. N. Dafny, M.A. Gilman, and F.J. Lichtigfeld Cholecystokinin induced suppression of feeding in fed, fasting and hypothalamic island rats Brain Res. Bull. 21 1988 225 231
61. N. Dafny, J.R. Lee, and P.M. Dougherty Immune response products after CNS activity: interferon modulates central opioid functions J. Neurosci. Res. 19 1988 130 139
62. N. Dafny, P.M. Dougherty, and N.R. Pellis The immune system and opiate withdrawal Int. J. Immunopharmacol. 11 1989 371 375
63. N. Dafny, B. Prieto-Gomez, W.Q. Dong, and C. Reyes-Vazquez Interferon modulates neuronal activity recorded from the hypothalamus, thalamus, hippocampus, amygdale and the somatosensory cortex Brain Res. 734 1996 269 274
64. N. Dafny, P.B. Yang, and S.A. Brod Interferons L. Martini Encyclopedia of Endocrine Diseases 2004 Academic Press San Diego, CA 53 59
65. R. Dantzer, E. Satinoff, and K.W. Kelley Cyclosporine and alpha-interferon do not attenuate morphine withdrawal in rats but do impair thermoregulation Physiol. Behav. 39 1987 593 598
66. J.J. Darling, N.R. Hoyle, and D.G.T. Thomas Self and non-self in the brain Immunol. Today 2 1981 176 181
67. G.B. De Sarro, Y. Masuda, C. Ascioti, M.G. Audino, and G. Nistico Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone Neuropharmacology 29 1990 167 179
68. R. De Simone, G. Levi, and F. Aloisi Interferon gamma gene expression in rat central nervous system glial cells Cytokine 10 1998 418 422
69. C.A. Dinarello Interleukin-1 Ann. N. Y. Acad. Sci. 546 1988 122 132
70. C.A. Dinarello Interleukin-1 and its biologially related cytokines Adv. Immunol. 44 1989 153 205
71. C.A. Dinarello Cytokines as endogenous pyrogens J. Infect. Dis. 179 1999 294 304
72. C.A. Dinarello, H.A. Bernheim, G.W. Duff, T.L. Nagabhushan, N.C. Hamilton, and F. Coceani Mechanisms of fever induced by recombinant human interferon J. Clin. Invest. 74 1984 906 913
73. P. Domanski, E. Fish, O.W. Naduea, M. Witte, L.C. Platanais, H. Yan, J. Krolewski, P. Pitha, and O.R. Colamonici A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state J. Biol. Chem. 272 1997 26388 26393
74. P.M. Dougherty, and N. Dafny Interaction of immune cytokine and CNS opioids: a possible interface for stress-induced immune suppression? J. Wybran R. Faith H.W. McCain N.P. Plotnikoff Stress and Immunity 1991 Plenum Press New York, NY 373 385
75. P.M. Dougherty, J. Aronowski, T. Samorajaski, and N. Dafny Opiate antinociception is altered by immunomodification: the effects of interferon, cyclosporine and radiation-induced immune suppression upon acute and long-term morphine activity Brain Res. 385 1986 401 404
76. P.M. Dougherty, C. Harper, and N. Dafny The effect of alpha-interferon, cyclosporine A and radiation-immune suppression on morphine-induced hypothermia and tolerance Life Sci. 39 1986 2191 2197
77. P.M. Dougherty, J. Pearl, K.J. Krajewski, N.R. Pellis, and N. Dafny Differential modification of morphine and methadone dependence by interferon-α Neuropharmacology 26 1987 1595 1600
78. A.J. Dunn Psychoneuroimmunology for the psychoneuroendocrinologist: a review of animal studies of nervous system-immune system interactions Psychoendocrinology 14 1989 251 260
79. A.L. Dunn, and L.S. Crnic Behavioral effects of repeated injections of interferon-α A/D in Balb/c mice Brain Behav. Immun. 6 1992 355 364
80. A.L. Dunn, and L.S. Crnic Repeated injections of interferon-α A/D in Balb/c mice: behavioral effects Brain Behav. Immun. 7 1993 104 111
81. U. Ernstrom, and O. Soder Influence of adrenaline on the dissemination of antibody-producing cells from the spleen Clin. Exp. Immunol. 21 1975 131 140
82. J. Fang, C.K. Sanborn, K.B. Renegar, J.A. Majde, and J.M. Krueger Influenza viral infections enhance sleep in mice Proc. Soc. Exp. Biol. Med. 210 1995 242 252
83. M. Färkkilä, M. Iivanainen, M. Härkönen, J. Laakso, K. Mattson, A. Niiranen, T.A. Larsen, and K. Cantell Effect of interferon-γ on biogenic amine metabolism, electroencephalographic recordings, and transient potentials Clin. Neuropharmacol. 11 1988 63 67
84. W.L. Farrar, J.M. Hill, A. Harel-Bellan, and M. Vinocour The immune logical brain Immunol. Rev. 100 1987 361 378
85. D.L. Felten, S.Y. Felten, D.L. Bellinger, S.L. Carlson, K.D. Ackerman, K.S. Madden, J.H. Olschowska, and S. Livnat Noradrenergic sympathetic neural interaction with the immune system: structure and function Immun. Rev. 100 1987 225 260
86. K. Fent, and G. Zbinden Toxicity of interferon and interleukin Trends Pharmacol. Sci. 8 1987 100 105
87. N. Gekakis, D. Staknis, H.B. Nguyen, F.C. Davis, L.D. Wilsbacher, D.P. King, J.S. Takanashi, and C.J. Weits Role of the CLOCK protein in the mammalian circadian mechanism Science 280 1988 1564 1569
88. S.C. Gilman, J.M. Schwartz, R.J. Milner, F.E. Bloom, and J.D. Feldman β-endorphin enhances lymphocyte proliferative response Proc. Natl. Acad. Sci U. S. A. 79 1982 4226 4230
89. W.F. Gober, S.S. Lefkowitz, and C.Y. Hung Effect of morphine, hydromorphine, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection Arch. Int. Pharmacodyn. 214 1975 322 327
90. D. Goldstein, and J. Laszlo The role of interferon in cancer therapy: a current perspective CA-A Cancer J. Clin. 38 1988 258 277
91. P.W. Gray, and D.V. Goeddel Structure of the human immune interferon gene Nature 298 1982 859 863
92. D.V. Habif, R. Lipton, and K. Cantell Interferon crosses blood-cerebrospinal fluid barrier in monkeys Proc. Soc. Exp. Biol. Med. 149 1975 287 289
93. R.D. Hadden, B. Sharrack, S. Bensa, S.E. Soudain, and R.A. Hughes Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy Neurology 53 1999 57 61
94. E. Hazum, K.J. Chang, and P. Cuatrecasas Specific non-opiate receptors for β-endorphin Science 205 1979 1033 1035
95. K.A. Holland, C.M. Owczarek, B.R. Hwang, M.J. Tymms, S.C. Constaninescu, L.M. Pfeffer, I. Kola, and P.J. Hertzog A type I interferon signaling factor, ISF21, encoded on chromosome 21 is distinct from receptor components and their down-regulation and is necessary for transcriptional activation of interferon-regulated genes J. Biol. Chem. 272 1997 21045 21051
96. L. Hood, J.L. Weissman, and J.H. Wilson Imunology 1984 Benjamin Cummings Publishing Co. Menio Park, CA 282 333
97. T. Hori, K. Kuriyama, and T. Nakashima Thermal responsiveness of neurons in the ventromedial nucleus of hypothalamus J. Physiol. Soc. Jpn. 50 1988 619
98. T. Hori, T. Nakashima, S. Take, Y. Kaizuka, T. Mori, and T. Katafuchi Immune cytokines and regulation of body temperature, food intake and cellular immunity Brain Res. Bull. 27 1991 309 313
99. C.Y. Hung, S.S. Lefkowitz, and W.F. Geber Interferon inhibition by narcotic analgesics Proc. Soc. Exp. Biol. Med. 142 1973 106 111
100. M. Iivanainen, R. Laaksonen, M.L. Niemi, M. Färkkilä, L. Bergström, K. Mattson, A. Niiranen, and K. Cantell Memory and psychomotor impairment following high-dose interferon treatment in amyotrophic lateral sclerosis Acta Neurol. Scand. 72 1985 475 480
101. K. Ikeda, M. Yoshii, I. Sora, and T. Kobayashi Opioid receptor coupling to GIRK channels. In vitro studies using a Xenopus oocyte expression system and in vivo studies on weaver mutant mice Z.Z. Pan Methods in Molecular Medicine 2003 Humana Press Totowa 53 64
102. A. Isaacs, and J. Lindenmann Virus interference: I. The interferon Proc. R. Soc. Lond., Ser. B 147 1957 258 267
103. J.H. Jaffe Drug addiction and drug abuse A.G. Gilman T.W. Rall A.S. Nies P. Taylor The Pharmacological Basis of Therapeutics 8th ed. 1990 Macmillan Publishing Co., Inc. New York 435 523
104. J.H. Jaffe, and W.R. Martin Opioid analgesics and antagonists A.G. Gilman T.W. Rall A.S. Nies P. Taylor L.S. Goodman The Pharmacological Basis of Therapeutics eighth ed. 1990 Macmillan Publishing Co., Inc. New York 435 521
105. P.K. Janicki Binding of human alpha-interferon in the brain tissue membranes of rat Res. Commun. Chem. Pathol. Pharmacol. 75 1992 117 120
106. B.D. Jankovic, and K. Isakovic Neuroendocrine correlates of the immune response: I. Effect of brain lesions on antibody production arthus reactivity and delayed hypersensitivity in the rat Int. Arch. Allergy 45 1973 360 372
107. C.L. Jiang, L.X. Song, C.L. Lu, Z.D. You, Y.X. Wang, L.Y. Sun, R.Y. Cui, and X.Y. Liu Analgesic effect of interferon-alpha via mu opioid receptor in the rat Neurochem. Int. 36 2000 193 196
108. X. Jin, L.P. Shearman, D.R. Weaver, M.J. Zylka, G.J.D. Vries, and S.M. Reppert A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock Cell 96 1999 57 68
109. N. Kaur, I.J. Kim, D. Higgins, and S.W. Halvorsen Induction of an interferon-γ Stat3 response in nerve cells by pre-treatment with gp130 cytokines N. Neurochem. 87 2003 437 447
110. F.W.L. Kerr, and J. Pozuelo Suppression of physical dependence and induction of the hypersensitivity to morphine by stereotaxic hypothalamus lesions in addicted rats Mayo Clin. Proc. 46 1971 653 665
111. D. Kidron, D. Saphier, H. Ovadia, J. Weidenfeld, and O. Abramsky Central administration of immunomodulatory factors alters neural activity and adrenocortical secretion Brain Behav. Immun. 3 1989 15 27
112. M. Kimura-Takeuchi, J.A. Majde, L.A. Toth, and J.M. Krueger Influenza virus-induced changes in rabbit sleep and acute phase responses Am. J. Physiol. 263 1992 R1115 R1121
113. H. Kirchner Interferon gamma Prog. Clin. Biochem. Med. 1 1984 169 203
114. T. Kobayashi, K. Washiyama, and K. Ikeda Effects of interferon-α on cloned opioid receptors expressed in Xenopus oocytes Life Sci. 76 2004 407 415
115. L.M. Kow, and D.W. Pfaff Actions of feeding-relevant agents on hypothalamic glucose-responsive neurons in vitro Brain Res. Bull. 15 1985 509 513
116. S. Koyanagi, and S. Ohdo Alteration of intrinsic biological rhythms during interferon treatment and its possible mechanism Mol. Pharmacol. 62 2002 1303 1309
117. J.M. Krueger, and J.A. Majde Cytokines and sleep Int. Arch. Allergy Immunol. 106 1995 97 100
118. J.M. Krueger, J.R. Pappenheimer, and M.L. Karnovsky The composition of sleep-promoting factor isolated from human urine J. Biol. Chem. 257 1982 1664 1669
119. J.M. Krueger, C.A. Dinarello, S. Shoham, D. Davenne, J. Walter, and S. Kubillus Interferon alpha-2 enhances slow-wave sleep in rabbits Int. J. Immunopharmacol. 9 1987 23 30
120. T. Kubota, J.A. Majde, R.A. Brown, and J.M. Krueger Tumor necrosis factor receptor fragment attenuates interferon-γ-induced non-REM sleep in rabbits J. Neuroimmunol. 119 2001 192 198
121. A. Kugaya, A. Kagaya, Y. Uchitomi, N. Yokota, and S. Yamawaki Effect of interferon-α on DOI-induced wet-dog shakes in rats J. Neural Transm. 103 1996 947 955
122. K. Kume, M.J. Zylka, S. Sritam, L.P. Shearman, D.R. Weaver, X. Jin, E.S. Maywood, M.H. Hastings, and S.M. Reppert mCRY1 and CRY2 are essential components of the negative limb of the circadian clock feedback loop Cell 98 1999 193 205
123. K. Kuriyama, T. Hori, T. Mori, and T. Nakashima Actions of interferon-α and interleukin-1β on the glucose-responsive neurons in the ventromedial hypothalamus Brain Res. Bull. 24 1990 803 810
124. J.A. Langer, and S. Pestka Interferon receptors Immunol. Today 9 1988 393
125. I. Larsson, L.E. Landstrom, E. Larner, E. Lundgren, H. Miorner, and O. Strannegard Interferon production in glia and glioma cell lines Infect. Immun. 22 1978 786 789
126. E. Laschka, A. Herz, and J. Blasig Sites of action of morphine involved in the development of physical dependence in rats I Psychopharmacologia 46 1976 133 139
127. L.R. Leon Hypothermia in systemic inflammation: role of cytokines Front. Biosci. 9 2004 1877 1888
128. M. Lewerenz, K.E. Mogensen, and G. Uze Shared receptor components but distinct complexes for alpha and beta interferons J. Mol. Biol. 282 1998 585 599
129. J. Li, and R.M. Roberts Interferon-tau and interferon-alpha interact with the same receptors in bovine endometrium. Use of a readily iodinatable form of recombinant interferon-tau for binding studies J. Biol. Chem. 269 1994 13544 13550
130. A. Lopker, L.G. Abood, W. Hoss, and F.J. Lionetti Stereoselective muscarine acetylcholine and opiate receptors in human phagocytic leukocytes Biochem. Pharmacol. 29 1980 1361 1365
131. M. Makino, Y. Kitano, C. Komiyama, M. Hirohashi, M. Kohno, M. Moriyama, and K. Takasuna Human interferon-α induces immobility in the mouse forced swimming test: involvement of the opioid system Brain Res. 852 2000 482 484
132. R. Marcovitz, H. Tsiang, and A.G. Hovannesiam Production and action of interferon in mice affected with rabies virus Ann. Virol. 135E 1984 19 33
133. L.E. Maroun Anti-interferon immunoglobulins can improve the trisomy 16 mouse phenotype Teratology 51 1995 329 335
134. L.E. Maroun, T. Hefferman, and D. Hallam The untoward side effects of interferon therapy correlate well with the spectrum of symptoms that make up the down syndrome Down Syndr. Res. Pract. 5 1998 143 147
135. L.E. Maroun, T.N. Hefferman, and D.M. Hallam Partial IFN-α/β and IFN-γ receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viability J. Interferon Cytokine Res. 20 2000 197 203
136. Y. Maruo Interferon production and natural killer activity of peripheral blood lymphocytes obtained from patients with multiple sclerosis Hokkaido J. Med. Sci. 63 1988 521 533
137. K. Mattson, A. Niiranen, M. Iivanainen, M. Färkkilä, L. Bergström, L.R. Holsti, and K. Cantell Neurotoxicity of interferon Cancer Treat. Rep. 67 1983 958 961
138. H.W. McCain, L.B. Lamster, J.M. Bozzone, and J.T. Grbic β-endorphin modulates human immune activity via non-opiate receptor mechanisms Life Sci. 31 1982 1619 1624
139. K.D. Meisheri, and G.E. Isom Influence of immune stimulation and suppression on morphine physical dependence and tolerance Res. Commun. Chem. Pathol. Pharmacol. 19 1978 85 99
140. R.A. Menzies, R. Patel, N.R.S. Hall, M.P. O'Grady, and S.E. Rier Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes Life Sci. 50 1992 PL227 PL232
141. C.A. Meyers, and A.D. Valentine Neurological and psychiatric adverse effects of immunological therapy CNS Drugs 3 1995 56 68
142. S.P. Montgomery, and N. Dafny Cyclophosphamide and cortisol reduce the severity of morphine withdrawal Int. J. Immunopharmacol. 9 1987 453 457
143. J.E. Morley Neuropeptide regulation of appetite and weight Endocr. Rev. 8 1987 256 287
144. M. Muller, J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. Harper, G. Barbieri, B. Witthulin, C. Schindler, S. Pellegrini, A. Wilks, J. Ihle, G. Stark, and I. Kerr The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and-gamma signal transduction Nature 366 1993 129 135
145. M.J. Murray, and A.B. Murray Anorexia of infection as a mechanism of host defense Am. J. Clin. Nutr. 32 1979 593 596
146. T. Nakashima, T. Hori, K. Kuriyama, and T. Kiyohara Naloxone blocks the interferon-α induced changes in hypothalamic neuronal activity Neurosci. Lett. 82 1987 332 336
147. T. Nakashima, T. Hori, K. Kuriyama, and T. Matsuda Effects of interferon-α on the activity of preoptic thermosensitive neurons in tissue slices Brain Res. 454 1988 361 367
148. T. Nakayama, K. Yamamoto, Y. Ishikawa, and K. Imai Effects of preoptic thermal stimulation on the ventromedial hypothalamic neurons in rats Neurosci. Lett. 26 1981 177 181
149. D. Novick, B. Cohen, and M. Rubinstein The human interferon alpha/beta receptor: characterization and molecular cloning Cell 77 1994 391 400
150. S. Ohdo, S. Koyanagi, H. Suyamam, S. Higuchi, and H. Aramaki Changing the dosing schedule minimizes the disruptive effects of interferon on clock function Nat. Med. 7 2001 356 360
151. T. Ono, Y. Oomura, H. Nishino, K. Sasaki, K. Muramoto, and I. Yano Morphine and enkephalin effects on hypothalamic glucosensitive neurons Brain Res. 185 1980 208 212
152. Y. Oomura Chemical and neuronal control of feeding motivation Physiol. Behav. 44 1988 555 560
153. K. Paucker, K. Cantell, and W. Henle Quantitative studies on viral interference in suspended L cells: III. Effect of interfering viruses and interferon on the growth rate of cells Virology 17 1962 324 334
154. L. Paulesu, M. Muscettola, V. Bocci, and A. Viti Daily variations of plasma interferon levels in the rat IRCS Med. Sci. 13 1985 993 994
155. M.A. Pavol, C.A. Meyers, J.L. Rexer, A.D. Valentine, P.J. Mattis, and M. Talpaz Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia Neurology 45 1995 947 950
156. N.R. Pellis, C. Harper, and N. Dafny Suppression of the induction of delayed hypersensitivity in rats by repetitive morphine treatments Exp. Neurol. 93 1986 92 97
157. S. Pestka The human interferon α species and receptors Biopolymers (Pept. Sci.) 55 2000 254 287
158. S. Pestka, J.A. Langer, K.C. Zoon, and C.E. Samuel Interferons and their actions Annu. Rev. Biochem. 56 1987 727 777
159. P.K. Peterson, T.W. Molitor, and C.C. Chao Mechanisms of morphine-induced immunomodulation Biochem. Pharmacol. 46 1993 343 348
160. C.R. Plata-Salaman Immunomodulators and feeding regulation: a humoral link between the immune and nervous system Brain Behav. Immun. 3 1989 193 213
161. C.R. Plata-Salaman Immunoregulators in the nervous system Neurosci. Behav. Rev. 15 1991 185 215
162. C.R. Plata-Salaman Interferons and central regulation of feeding Am. J. Physiol. 263 1992 R1222 R1227
163. C.R. Plata-Salaman Cytokines and anorexia: a brief overview Semin. Oncol. 1 1998 64 72
164. C.R. Plata-Salamán, Y. Oomura, and Y. Kai Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system Brain Res. 448 1988 106 114
165. B. Prieto-Gomez, C. Reyes-Vazquez, and N. Dafny Microiontophoretic application of morphine and naloxone in rat hypothalamus neurons Neuropharmacology 23 1981 1081 1089
166. B. Prieto-Gomez, C. Reyes-Vazquez, and N. Dafny Differential effects of interferon on ventromedial hypothalamus and dorsal hippocampus J. Neurosci. Res. 10 1983 273 278
167. J. Pritchard, I.A. Gray, Z.R. Idrissova, B.R.F. Lecky, I.J. Sutton, A.V. Swan, H.J. Willison, J.B. Winer, and R.A.C. Hughes A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barre syndrome Neurology 61 2003 1282 1284
168. J.R. Quesada, M. Talpaz, A. Rias, R. Kurzrock, and J.U. Gutterman Clinical toxicity of interferons in cancer patients: a review J. Clin. Oncol. 4 1986 234 243
169. A.T. Reder Regulation of production of adrenocotricotropin-like proteins in human mononuclear cells Immunology 77 1992 436 442
170. L. Redwine, J. Dang, M. Hall, and M. Irwin Disordered sleep, nocturnal cytokines, and immunity in alcoholics Psychosom. Med. 65 2003 75 85
171. M. Reite, M. Laudenslager, J. Jones, L. Crnic, and K. Keamingk Interferon decreases REM latency Biol. Psychol. 22 1987 104 107
172. C. Reyes-Vazquez, B. Prieto-Gomez, and N. Dafny Novel effects of interferon on the brain: microiontophoretic application and single cell recording Neurosci. Lett. 34 1982 201 206
173. C. Reyes-Vazquez, B. Prieto-Gomez, J.A. Georgiades, and N. Dafny Alpha and gamma interferons effects on cortical and hippocampal neurons: microiontophoretic application and single cell recording Int. J. Neurosci. 25 1984 113 121
174. C. Reyes-Vazquez, N. Weisbrodt, and N. Dafny Does interferon exert its action through opiate receptors? Life Sci. 35 1984 1015 1021
175. C. Reyes-Vazquez, B. Prieto-Gomez, and N. Dafny Alpha-interferon suppresses food intake and neuronal activity of the lateral hypothalamus Neuropharmacology 33 1994 1545 1552
176. C. Reyes-Vazquez, V. Mendoza-Fernandez, M. Herrera-Rhiz, and N. Dafny Interferon modulates glucose sensitive neurons in the hypothalamus Exp. Brain Res. 116 1997 519 524
177. J.A. Ripperger, L.P. Shearman, S.M. Reppert, and U. Schibler CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP Genes Dev. 15 2000 679 689
178. A.Z.S. Rohatiner, P.F. Prior, A.C. Burton, A.T. Smith, F.R. Balkwill, and T.A. Lister Central nervous system toxicity of interferon Br. J. Cancer 47 1983 419 422
179. R.S. Root-Bernstein 'Molecular sandwiches' as a basis for structural and functional similarities of interferons, MSH, ACTH, LHRH, myelin basic protein, and albumins FEBS Lett. 168 1984 208 212
180. S. Roy, and H.H. Loh Effects of opioids on the immune system Neurochem. Res. 21 1996 1375 1386
181. S. Sakami, T. Ishikawa, N. Kawakami, T. Haratani, A. Fukui, F. Kobayashi, O. Fujita, S. Araki, and N. Kawamura Coemergence of insommia and a shift in the Th1/Th2 balance toward Th2 dominance Neuroimmunomodulation 10 2002 337 343
182. C.E. Samuel Antiviral actions of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities Virology 183 1991 1 11
183. D. Saphier, D. Kidron, H. Ovadia, J. Weidenfeld, O. Abramsky, Y. Burstein, M. Pecht, and N. Trainin Preoptic area (POA) multiunit activity (MUA) and cortical EEG changes following intracerebroventricular (ICV) administration of α-interferon (IFN), thymic humoral factor (THF), histamine (HIS), and interleukin-1 (IL-1) Rev. Clin. Basic Pharmacol. 6 1987 265 278
184. D. Saphier, D. Kidron, O. Abramsky, N. Trainin, M. Pecht, Y. Burstein, and H. Ovadia Neurophysiological changes in the brain following central administration of immunomodulatory factors Isr. J. Med. Sci. 24 1988 261 263
185. 1-opioid receptors in the rat Eur. J. Pharmacol. 236 1993 186 194
186. D. Saphier, S.C. Roerig, C. Ito, W.R. Vlasak, G.E. Farrar, J.E. Broyles, and J.E. Welch Inhibition of neural and neuroendocrine activity by α-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat Brain Behav. Immun. 8 1994 37 56
187. M. Schaefer, T. Messer, U. Wegner, M.H. Schmid-Wendtner, and M. Volkenandt Psychiatric side effects during adjuvant therapy with interferon-alphain patients with malignant melanoma: clinical evaluation as well as diagnostic and therapeutic possibilities Hautarzt 50 1999 654 658
188. M. Schaefer, M. Schwaiger, M. Pich, K. Lieb, and A. Heinz Neurotransmitter changes by interferon-alpha and therapeutic implications Pharmacopsychiatry 36 2003 203 206
189. B. Schaller, A.J. Radziwill, and A.J. Steck Successful treatment of Guillain-Barre syndrome with combined administration of interferon-beta-1a and intravenous immunoglobulin Eur. Neurol. 46 2001 167 168
190. M.C. Schanzer, E.D. Jacobson, and N. Dafny Endocrine control of appetite: gastrointestinal hormonal effects on CNS appetite structures Neuroendocrinology 25 1978 329 342
191. J. Schlessinger, and A. Ullrich Growth factor signaling by receptor tyrosine kinases Neuron 9 1992 383 391
192. G.M. Scott, D.S. Secher, D. Flowers, J. Bate, K. Cantell, and D.A.J. Tyrrell Toxicity of interferon Br. Med. J. 282 1981 1345 1348
193. M.A. Segall, and L.S. Crnic An animal model for the behavioral effects of interferon Behav. Neurosci. 104 1990 612 618
194. Y. Shavit, J.W. Lewis, W.G. Terman, R.P. Gale, and J.C. Liebeskind Opioid
195. M. Shibata, and C.M. Blatteis Differential effects of cytokines on thermosensitive neurons in guinea pig preoptic area slices Am. J. Physiol. 261 1992 R1096 R1103
196. S. Shoham, D. Davenne, A.B. Cady, C.A. Binarello, and J.M. Krueger Recombinant tumor necrosis factor and interleukin 1 enhance slow wave sleep Am. J. Physiol. 253 1987 R142 R149
197. K. Shuai, G.R. Stark, I.M. Kerri, and J.E. Darnell A single phosphotyrosine residue of Sta91 required for gene activation by interferon-gamma Science 261 1993 1744 1746
198. O. Silvennoinen, J.N Ihle, J. Schlessinger, and D.E. Levy Interferon-induced nuclear signalling by Jak protein tyrosine kinases Nature 366 1993 583 585
199. H. Smedley, M. Katrak, K. Sikora, and T. Wheeler Neurological effects of recombinant human interferon Br. Med. J. 286 1983 262 264
200. E.M. Smith, and J.E. Blalock Human lymphocyte production of corticotrophin and endorphin-like substances: association with leukocyte interferon Proc. Natl. Acad. Sci. U. S. A. 78 1981 7530 7543
201. R.A. Smith, F. Norris, D. Palmer, L. Bernhardt, and R.J. Wills Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration Clin. Pharmacol. Ther. 37 1985 85 88
202. R.A. Smith, C. Landel, C.E. Cornelius, and M. Revel Mapping the action of interferon on primate brain J. Interf. Res. 6 1986 140
203. G.F. Solomon Psychoneuroimmunology: interactions between central nervous system and immune system J. Neurosci. Res. 18 1987 1 12
204. J.M. Soos, and B.E. Szente Type I interferons [IFNα, β, δ, ω, τ, IL-28A (IFNλ2) IL-28B (IFNλ3) and IL-29 (IFN λ1)] A.W. Thomson M.T. Lotze The Cytokine Handbook 2003 Academic Press London, England 549 566
205. E. Späth-Schwalbe, F. Porzsolt, W. Digel, J. Born, B. Kloss, and H.L. Fehm Elevated plasma cortisol levels during interferon-γ treatment Immunopharmacology 17 1989 141 145
206. E. Spath-Schwalbe, T. Lange, B. Perras, H.L. Fehm, and J. Born Interferon-α acutely impairs sleep in healthy humans Cytokine 12 2000 518 521
207. N.H. Spector, and E.A. Korneva Neurophysiology/immunopharmacology and neuroimmunomodulation R. Ader Psychoneuroimmunology 1981 Academic Press New York 449 473
208. G.R. Stark, I.M. Kerr, B.R.G. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Annu. Rev. Biochem. 67 1998 227 264
209. S. Take, T. Katafuchi, D. Ando, Y. Uchimura, Y. Kanemitsu, T. Ichijo, N. Shimizu, T. Hori, and T. Kosaka Hypothalamic interferon-α reduces splenic NK cytotoxicity Soc. Neurosci. Abstr. 18 1992 681
210. S. Take, T. Mori, T. Kaizuka, T. Katafuchi, and T. Hori Central interferon α suppresses the cytotoxic activity of natural killer cells in the mouse spleen Ann. N. Y. Acad. Sci. 650 1992 46 50
211. S. Take, T. Mori, T. Katafuchi, and T. Hori Central interferon α inhibits natural killer cytotoxicity through sympathetic innervation Am. J. Physiol. 265 1993 R453 R459
212. H. Teitelbaum, G.N. Catravas, and W.L. McFarland Reversal of morphine tolerance after medial thalamic lesions in the rat Science 185 1974 449 451
213. D.L. Tempel, T. Kim, and S.F. Liebowitz The paraventricular nucleus is uniquely responsive to the feeding stimulatory effects of steroid hormones Brain Res. 614 1993 197 204
214. Y. Uchimura, N. Uchimura, R. Kumashiro, A. Hattori, and M. Sata Changes in melatonin concentrations during IFN therapy J. Hepatol. 31 1999 1131
215. G. Uzé, G. Lutfalla, and K.E. Mogensen α and β Interferons and their receptor and their friends and relations J. Interferon Cytokine Res. 15 1995 3 26
216. A.D. Valentine, C.A. Meyers, and M. Talpaz Treatment of neurtoxic side effects of interferon-alpha with naltrexone Cancer Investig. 13 1995 561 566
217. A.D. Valentine, C.A. Meyers, M.A. Kling, E. Richelson, and P. Hauser Mood and cognitive side effects of interferon-alpha therapy Semin. Oncol. 25 1998 39 47
218. J.M. Vallat, A.F. Hahn, and J.M. Leger Interferon beta-1a as an investigational treatment for CIDP Neurology 60 2003 23S 28S
219. P. Van der Geer, T. Hunter, and R.A. Lindberg Receptor protein-tyrosine kinases and their signal transduction pathways Annu. Rev. Cell Biol. 10 1994 251 337
220. K. Vass, and H. Lassmann Intrathecal application of interferon gamma: progressive appearance of MHC antigens within the rat nervous system Am. J. Pathol. 137 1990 789 800
221. J. Vernikos-Danellis, K.J. Kellar, D. Dent, C. Gonzolas, P.A. Gerger, and J.D. Barches Serotonin involvement in pituitary-adrenal function Ann. N. Y. Acad. Sci. 297 1977 518 526
222. J. Vilcek, M.H. Ng, A.E. Friedman-Klein, and T. Krawciw Induction of interferon synthesis by synthetic double-stranded polynucleotides J. Virol. 2 1968 648 650
223. M.R. Walters, R. Bordens, T.L. Nagabhushan, B.R. Williams, R.B. Herberman, C.A. Dinarello, E.C. Bordern, P.P. Trotta, S. Pestka, and L.M. Pfeffer Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon Cancer Biother. Radiopharm. 13 1998 143 154
224. J. Wang, R.A. Barke, R. Charboneau, H.H. Loh, and S. Roy Morphine negatively regulates interferon-γ promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways J. Biol. Chem. 278 2003 37622 37631
225. E. Wei Quantification of precipitated abstinence in morphine dependent rats Fed. Proc. 31 1971 527
226. M. Wichers, and M. Maes The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans Int. J. Neuropsychopharmacol. 5 2002 375 388
227. S. Wieczorek, N. Daheman, M. Kasten, J.T. Epplen, and M. Genick A rare form of narcolepsy (HLA-DR2) shows possible association with (functionally relevant) alpha-interferon gene polymorphisms Psychiatr. Genet. 14 2004 47 51
228. M. Wiranowska, T.C. Wilson, K. Thompson, and L.D. Prockop Cerebral interferon entry in mice after osmotic alteration of blood-brain barrier J. Interf. Res. 9 1989 355 362
229. S.C. Woods, and E.M. Stricker Food intake and metabolism M.J. Zigmond F.E. Bloom S.C. Landis J.L. Roberts L.R. Squire Fundamental Neuroscience 1999 Academic Press New York, NY 1091 1109
230. J. Wybran, T. Appleton, J.-P. Famaey, and A. Govaerts Suggestive evidence for methionine-enkephalin on normal human blood T lymphocytes J. Immunol. 123 1979 1068 1070
231. B.G. Xiao, and H. Link IFN-γ production of adult rat astrocytes triggered by TNF-α NeuroReport 9 1998 1487 1490
232. H. Yan, F. Piazza, K. Krishnan, R. Pine, and J.J. Krolewski Definition of the interferon α receptor-binding domain on the TYK2 kinase J. Biol. Chem. 273 1998 4046 4051
233. K. Yasuda Sustained release formulation of interferon Biomed. Ther. 27 1993 1221 1223
234. E. Zimmerman, and W. Krivoy Antagonism between morphine and the polypeptides ACTH, ACTH1-24, and B-MSH in the nervous system Prog. Brain Res. 39 1973 383 392
235. L.P. Zou, D.H. Ma, L. Wei, P.H. van der Meide, E. Mix, and J. Zhu IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue J. Neurosci. Res. 56 1999 123 130